CEO Doug Biehn sits down with Nasdaq’s Leigh Hixon to share Octave’s vision of transforming neurodegenerative disease care through precision medicine. Watch Now
CEO Doug Biehn sits down with Nasdaq’s Leigh Hixon to share Octave’s vision of transforming neurodegenerative disease care through precision medicine. Watch Now
Your partner in precision care for multiple sclerosis (MS) and beyond.
Your partner in precision care for multiple sclerosis (MS) and beyond.
Current measurement systems are subjective, qualitative, and inadequate. Without clarity, everyone within the ecosystem faces suboptimal outcomes.
Limited support and care coordination; lack of clarity about disease progression
Lack of objective and quantitative measurements for clinical decision-making
Escalating costs, top 3 drug spend, high variation in care, and avoidable utilization
Lack of precision tools and real-world insights to guide development
From subjective assessments to objective understanding
At Octave, we believe knowledge is power. We enable a new paradigm of care through our MS Precision Care Solution, complementing the art of medicine with new multi-dimensional care insights.
We routinely seek out meaningful evidence to assess and validate these tools in the clinical setting.
Our intelligence platform is continuously learning to deliver optimal care insights.
We’re committed to support and partnership. Our team will be with you every step of the way, from adoption to optimization.
A passionate team with a purpose
On a mission to power harmonious care for MS
Committed to continuously learning and sharing knowledge
